Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-14

Clinical Trial Update: An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated Abbott Diabetes Care's novel glucose-sensing technology for Type 2 Diabetes, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Diabetes Care | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2017-04-14